{"id": "1356068911708581888", "creation": 1612146997.0, "user_id": "3139655635", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "Shares of #Chinese vaccine developer CanSino Biologics surged around 13% to HK$285 ($36.77) by 10:30 am Monday, after the company announced that its recombinant #COVID19 #vaccine #Ad5-nCoV has met its pre-specified primary safety and efficacy criteria. https://t.co/X9z1dixLZp", "first_save": 1634559108.199414, "hashtags": ["#CHINESE", "#COVID19", "#VACCINE", "#AD5"]}